Works by Guo, Zhiqiang


Results: 192
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Self-protective DNAzyme-based dual-responsive three-way Y-probe for simultaneous determination of multiple pathogenic bacteria: Self-protective DNAzyme-based dual-responsive three-ways Y-probe for simultaneous determination of multiple pathogenic bacteria: B. Li et al

    Published in:
    Analytical & Bioanalytical Chemistry, 2025, v. 417, n. 9, p. 1779, doi. 10.1007/s00216-025-05782-7
    By:
    • Li, Bowen;
    • Ren, Xinru;
    • Xiao, Yijing;
    • Sun, Weiqing;
    • Yang, Meili;
    • Pang, Tsing-ao;
    • Zhu, Rui;
    • Guo, Zhiqiang;
    • Wang, Yu;
    • Liu, Su;
    • Huang, Jiadong
    Publication type:
    Article
    28
    29
    30
    31

    Prediction of ship collision risk based on CART.

    Published in:
    IET Intelligent Transport Systems (Wiley-Blackwell), 2018, v. 12, n. 10, p. 1345, doi. 10.1049/iet-its.2018.5281
    By:
    • Li, Yishan;
    • Guo, Zhiqiang;
    • Yang, Jie;
    • Fang, Hui;
    • Hu, Yongwu
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Negative pressure pulmonary edema (Review).

    Published in:
    Experimental & Therapeutic Medicine, 2023, v. 26, n. 3, p. N.PAG, doi. 10.3892/etm.2023.12154
    By:
    • Ma, Jin;
    • Liu, Tiantian;
    • Wang, Qiang;
    • Xia, Xiaohua;
    • Guo, Zhiqiang;
    • Feng, Qiupeng;
    • Zhou, Yan;
    • Yuan, Hua
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.

    Published in:
    Platelets, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09537104.2022.2157806
    By:
    • Xiaofan Liu;
    • Yusheng Bai;
    • Tao Wang;
    • Yanping Song;
    • Feng Sun;
    • Ruixiang Xia;
    • Feiyue Zhu;
    • Jun Ma;
    • Quanyi Lu;
    • Xu Ye;
    • Xinrong Zhan;
    • Linjie Li;
    • Xinhong Guo;
    • Shuqin Cheng;
    • Yan Li;
    • Zhiqiang Guo;
    • Youhua Chen;
    • Shenxian Qian;
    • Ling Qin;
    • Qing Zhang
    Publication type:
    Article
    50

    Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.

    Published in:
    Platelets, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09537104.2022.2157806
    By:
    • Liu, Xiaofan;
    • Bai, Yusheng;
    • Wang, Tao;
    • Song, Yanping;
    • Sun, Feng;
    • Xia, Ruixiang;
    • Zhu, Feiyue;
    • Ma, Jun;
    • Lu, Quanyi;
    • Ye, Xu;
    • Zhan, Xinrong;
    • Li, Linjie;
    • Guo, Xinhong;
    • Cheng, Shuqin;
    • Li, Yan;
    • Guo, Zhiqiang;
    • Chen, Youhua;
    • Qian, Shenxian;
    • Qin, Ling;
    • Zhang, Qing
    Publication type:
    Article